We have developed novel di-, tri-,
and tetrafunctional benzoxazine monomers (BZ2, BZ3, and BZ4), solely
containing benzoxazine moieties arranged one after the other on the
backbone, to discover the role of additional oxazine moiety on thermal
properties. A tandem reaction was adapted, at first a ring-closure
and then subsequent Mannich condensation by reacting 2-((4-hydroxyphenyl)aminomethyl)phenol
(HPAMP) and aniline/4-amino-2-((phenylamino)methyl)phenol/4-amino-2-(((4-hydroxy-3-((phenylamino)methyl)phenyl)amino)methyl)phenol
in the presence of paraformaldehyde to obtain BZ2/BZ3/BZ4. Tetrafunctional
benzoxazine monomers containing an intermediate group (R-BZ4) were
also synthesized by reacting HPAMP and p-phenylenediamine/4,4′-diaminodiphenylmethane
(PDA/DDM) to understand the differences in thermal properties due
to the distance created by those between two benzoxazine moieties.
The observations (in DSC and TGA analysis) with increase in number
of oxazine rings include (i) reduction in curing temperature from
264 °C (BZ1) to 237 °C (BZ4), however an intermediate distance
between BZ4 increased curing temperature to 245 °C (DDM); (ii)
slower curing rate, a complete curing was achieved only by heating
above 200 °C; (iii) decreased weight loss during ring-opening
polymerization, BZ1:90% to BZ4:2.4%; (iv) increase in T
g up to 315 °C; and (v) similar thermal stability
for BZ2 to BZ4. Introduction of an intermediate between two oxazine
rings in a tetrafunctional benzoxazine (R-BZ4) was found to be the
best strategy to obviate weight loss during curing as well as to enhance
the thermal degradation temperature of resulting polybenzoxazine (PDDM: T
d10 of 395 °C).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.